drugset / Trial / NCT03192371

A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children

NCT03192371

Phase 4 Withdrawn GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the 1 year immunogenicity persistence of Rabipur in children 6-17 years of age, and compare the Zagreb regimen with the Essen regimen.

Timeline

Start
2018-02-15
Primary completion
2019-05-12
Completion
2019-05-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabies vaccine Vaccine Intramuscular